Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system.

Blood 2011 Mar 3;117(11):3140-6. Epub 2011 Jan 3.

Department of Medicine, Hematology, and Oncology, Ruhr-University of Bochum, Germany.

The diagnosis of primary central nervous system lymphoma (PCNSL) depends on histopathology of brain biopsies, because disease markers in the cerebrospinal fluid (CSF) with sufficient diagnostic accuracy are not available yet. MicroRNAs (miRNAs) are regulatory RNA molecules that are deregulated in many disease types, including cancer. Recently, miRNAs have shown promise as markers for cancer diagnosis. In this study, we demonstrate that miRNAs are present in the CSF of patients with PCNSL. With a candidate approach and miRNA quantification by reverse transcription polymerase chain reaction, miRNAs with significant levels in the CSF of patients with PCNSL were identified. MiR-21, miR-19, and miR-92a levels in CSF collected from patients with PCNSL and from controls with inflammatory CNS disorders and other neurologic disorders indicated a significant diagnostic value of this method. Receiver-operating characteristic analyses showed area under the curves of 0.94, 0.98, and 0.97, respectively, for miR-21, miR-19, and miR-92a CSF levels in discriminating PCNSL from controls. More importantly, combined miRNA analyses resulted in an increased diagnostic accuracy with 95.7% sensitivity and 96.7% specificity. We also demonstrated a remarkable stability of miRNAs in the CSF. In conclusion, CSF miRNAs are potentially useful tools as novel noninvasive biomarker for the diagnosis of PCNSL.

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-09-308684DOI Listing
March 2011
19 Reads

Publication Analysis

Top Keywords

patients pcnsl
12
diagnostic accuracy
8
mir-21 mir-19
8
levels csf
8
pcnsl controls
8
central nervous
8
cerebrospinal fluid
8
mir-19 mir-92a
8
nervous system
8
mirnas csf
8
csf patients
8
csf
7
mirnas
6
pcnsl
6
csf collected
4
collected patients
4
cns disorders
4
indicated diagnostic
4
diagnostic method
4
disorders indicated
4

References

(Supplied by CrossRef)
Article in Journal of Clinical Oncology
Journal of Clinical Oncology 2005

Pels et al.
2006
Article in Journal of Clinical Oncology
Journal of Clinical Oncology 2003
Article in Annals of neurology
Juergens et al.
Annals of neurology 2010
Article in European journal of haematology
Schroers et al.
European journal of haematology 2010
Article in Neuro-Oncology
Neuro-Oncology 2010
Article in Neurology
Fischer et al.
Neurology 2008
Article in Journal of Clinical Oncology
Journal of Clinical Oncology 2008
Article in Blood
Kersten et al.
Blood 1996
Article in European journal of haematology
Schroers et al.
European journal of haematology 2010
Article in British journal of haematology
Lawrie et al.
British journal of haematology 2007

Similar Publications